🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of acetaminophen, asserting the companies withheld safety concerns that the drug posed to children's brain development.

The court filing comes thirty days after President Donald Trump promoted an unproven link between consuming acetaminophen - referred to as acetaminophen - while pregnant and autism in children.

Paxton is taking legal action against J&J, which formerly manufactured the drug, the sole analgesic approved for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he claimed they "deceived the public by gaining financially from suffering and promoting medication ignoring the dangers."

Kenvue asserts there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to line their pockets," the attorney general, a Republican, stated.

The company commented that it was "very worried by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its website, the company also said it had "continuously evaluated the pertinent research and there is no credible data that shows a verified association between taking acetaminophen and autism spectrum disorder."

Groups representing doctors and medical practitioners share this view.

ACOG has stated acetaminophen - the main ingredient in Tylenol - is a restricted selection for pregnant women to address discomfort and elevated temperature, which can create serious health risks if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the use of acetaminophen in any period of gestation results in brain development issues in young ones," the organization stated.

The lawsuit cites current declarations from the former administration in asserting the medication is allegedly unsafe.

Recently, Trump caused concern from public health officials when he instructed expectant mothers to "struggle intensely" not to take acetaminophen when unwell.

Federal regulators then issued a notice that medical professionals should contemplate reducing the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism in minors has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in spring to conduct "a massive testing and research effort" that would establish the source of autism in a short period.

But experts advised that finding a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a complicated interplay of inherited and external influences - would prove challenging.

Autism is a form of enduring cognitive variation and disability that influences how individuals experience and relate to the environment, and is identified using physician assessments.

In his court filing, the attorney general - who supports Trump who is campaigning for the Senate - claims Kenvue and J&J "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism.

The lawsuit attempts to require the firms "eliminate any promotional materials" that states acetaminophen is reliable for expectant mothers.

This legal action echoes the grievances of a assembly of guardians of young ones with autism spectrum disorder and ADHD who filed suit against the makers of Tylenol in 2022.

Judicial authorities dismissed the case, stating research from the parents' expert witnesses was not conclusive.